Lionsgate director awarded 13,405 and 5,362 shares

Lionsgate Studios Corp. director Harry Sloan reported equity-based awards and fee payments in common shares, adding to his restricted share unit holdings.

Rhea-AI Filing Summary

Lionsgate Studios Corp. (LION) reported that director Harry Sloan acquired common shares on September 15, 2026 through equity compensation. He received 13,405 common shares at no cost as an annual director equity award and 5,362 common shares at $11.19 per share as director fees paid in common shares. A related footnote states that his holdings include 33,512 restricted share units, scheduled to vest in tranches on November 28, 2026 and September 15, 2027, each payable in an equal number of common shares. No Rule 10b5-1 trading plan is reported for these awards.

Insider Trade Summary

Grant/Award: 18,767 shares

Grant/Award 2 txns

Insider SLOAN HARRY

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares F1, F2	13,405	$0.00	$0.00
Grant/Award	Common Shares F3, F2	5,362	$11.19	$60K

Holdings After Transaction: Common Shares — 434,680 shares (Direct)

Footnotes (3)

1. F1. Annual director equity award.
2. F2. Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
3. F3. Director fees paid in common shares.

Key Figures

Annual director equity award shares: 13,405 shares Director fees paid in shares: 5,362 shares Equity award price: $0.00 per share +4 more

7 metrics

Annual director equity award shares 13,405 shares Common shares granted to director Harry Sloan on September 15, 2026 at $0.00 per share

Director fees paid in shares 5,362 shares Common shares issued as director fees on September 15, 2026 at $11.19 per share

Equity award price $0.00 per share Price for 13,405-share annual director equity award to Harry Sloan

Director fee share price $11.19 per share Price for 5,362 common shares issued as director fees

RSUs vesting November 28, 2026 20,107 restricted share units Restricted share units scheduled to vest and settle in common shares

RSUs vesting September 15, 2027 13,405 restricted share units Restricted share units scheduled to vest and settle in common shares

Total RSUs referenced 33,512 restricted share units Sum of RSUs scheduled to vest in 2026 and 2027, payable in common shares

Key Terms

restricted share units, annual director equity award, director fees paid in common shares

3 terms

restricted share units financial

"Amount includes the following restricted share units granted by the Issuer"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

annual director equity award financial

"Annual director equity award."

director fees paid in common shares financial

"Director fees paid in common shares."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did LION director Harry Sloan report on September 15, 2026?

He reported acquiring 13,405 common shares as an annual director equity award and 5,362 common shares as director fees paid in common shares, both dated September 15, 2026.

At what price were the Lionsgate Studios Corp. (LION) shares issued to Harry Sloan?

The 13,405 annual director equity award shares were granted at $0.00 per share, and the 5,362 shares representing director fees were issued at $11.19 per share.

Does the Form 4 indicate a Rule 10b5-1 plan for LION director Harry Sloan?

No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and there is no footnote stating that the transactions were made under a Rule 10b5-1 or similar trading plan.

What restricted share units does LION director Harry Sloan hold according to this filing?

A footnote states he holds 20,107 restricted share units scheduled to vest on November 28, 2026, and 13,405 restricted share units scheduled to vest on September 15, 2027, each payable in an equal number of common shares.

Are Harry Sloan’s Lionsgate Studios Corp. (LION) transactions direct or indirect holdings?

Both reported acquisitions are classified as direct ownership of common shares, with no separate entity or trust listed as the owner in the nature-of-ownership field.

Did Harry Sloan sell any Lionsgate Studios Corp. (LION) shares in this Form 4?

No. The Form 4 reports only acquisitions of common shares via equity awards and fees; there are no sales, gifts, or derivative exercises disclosed in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:53 PM Accepted by SEC EDGAR 09/17/2026 - 04:53 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SLOAN HARRY

(Last) (First) (Middle)

LIONSGATE

2700 COLORADO AVE.

(Street)

SANTA MONICA CALIFORNIA 90404

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lionsgate Studios Corp. [ LION ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/15/2026		A		13,405(1)	A	$0	429,318(2)	D
Common Shares	09/15/2026		A		5,362(3)	A	$11.19	434,680(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual director equity award.

2. Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.

3. Director fees paid in common shares.

Remarks:

	Harry Sloan (By Adrian Kuzycz by Power of Attorney)	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)